Skip to main content
AMCP 2026 Main banner

Drugs, Diseases, and the Managed Care Impact

(D2) Beyond the Breakthrough: Practical Insights for the Complex Gene Therapy Market

Tuesday, April 14, 2026
1:30 PM - 2:45 PM CT
Location: Davidson A
CPE
ACPE UAN: 0233-0000-26-009-L04-P | Contact Hours: 1.25 | Activity Type: Knowledge-based
Gene therapies are rapidly reshaping the treatment landscape. Despite scientific breakthroughs, adoption across payers and disease states remains uneven, and managing these high-cost therapies continues to pose a challenge for managed care organizations. This session will trace the evolution of gene therapy products and their implications for clinical practice. Faculty will present insights regarding real-world uptake and utilization management strategies adopted by regional and national health plans, providing attendees with a robust knowledge base regarding coverage, access, and barriers across various disease states, as well as a look at the innovative pipeline.

Learning Objectives:

At the completion of this activity, participants should be able to:
  1. Describe the evolution of gene therapy products in the United States.
  2. Discuss current utilization trends and uptake patterns for approved gene therapies across various disease states.
  3. Review utilization management strategies implemented by national and regional health plans.
  4. Summarize the mechanism of action, potential indications, and clinical portfolio of novel gene therapies in the next 12 months.